CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-11 | Kinney Gene G. President and CEO | Option exercise · Stock Option (Right to Buy) | −13,650 | 41,597 | ||
| 2022-08-10 | Kinney Gene G. President and CEO | Option exercise | +991 | $6.41 | $6K | 13,784 |
| 2022-08-10 | Kinney Gene G. President and CEO | Sale | −991 | $32.01 | $32K | 12,793 |
| 2022-08-10 | Kinney Gene G. President and CEO | Option exercise · Stock Option (Right to Buy) | −991 | 55,247 | ||
| 2022-08-05 | Kinney Gene G. President and CEO | Option exercise | +21,506 | $6.41 | $138K | 34,299 |
| 2022-08-05 | Kinney Gene G. President and CEO | Sale | −16,833 | $32.77 | $552K | 17,466 |
| 2022-08-05 | Kinney Gene G. President and CEO | Sale | −4,673 | $33.06 | $155K | 12,793 |
| 2022-08-05 | Kinney Gene G. President and CEO | Option exercise · Stock Option (Right to Buy) | −21,506 | 56,238 | ||
| 2022-08-04 | Kinney Gene G. President and CEO | Option exercise | +20,954 | $6.41 | $134K | 33,747 |
| 2022-08-04 | Kinney Gene G. President and CEO | Sale | −20,954 | $32.18 | $674K | 12,793 |
| 2022-08-04 | Kinney Gene G. President and CEO | Option exercise · Stock Option (Right to Buy) | −20,954 | 77,744 | ||
| 2022-08-01 | Garren Hideki Chief Medical Officer | Option exercise | +4,000 | $24.90 | $100K | 4,000 |
| 2022-08-01 | Garren Hideki Chief Medical Officer | Sale | −4,000 | $30.52 | $122K | 0 |
| 2022-08-01 | Garren Hideki Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −4,000 | 238,000 | ||
| 2022-07-27 | Kinney Gene G. President and CEO | Option exercise | +376 | $6.41 | $2K | 13,169 |
| 2022-07-27 | Kinney Gene G. President and CEO | Sale | −376 | $32.00 | $12K | 12,793 |
| 2022-07-27 | Kinney Gene G. President and CEO | Option exercise · Stock Option (Right to Buy) | −376 | 98,698 | ||
| 2022-07-22 | Nguyen Tran Chief Strategy Officer and CFO | Option exercise | +7,320 | $6.73 | $49K | 10,520 |
| 2022-07-22 | Nguyen Tran Chief Strategy Officer and CFO | Sale | −7,320 | $32.55 | $238K | 3,200 |
| 2022-07-22 | Nguyen Tran Chief Strategy Officer and CFO | Option exercise · Stock Option (Right to Buy) | −7,320 | 80,000 |
Page 26 of 28 · 555 trades